The role of cathelicidins in the innate host defenses of mammals

Current Issues in Molecular Biology

Volumn 7, Issue 2, 2005, Pages 179-196

  Zanetti, Margherita ^a,b  

^a UNIVERSITY OF UDINE   (Italy)

^b National Laboratory CIB   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; BMAP 27; BMAP 28; BMAP 34; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD4 ANTIGEN; COMPLEMENTARY DNA; DODECAPEPTIDE; INDOLICIDIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PMAP 23; PMAP 36; PMAP 37; POLYPEPTIDE ANTIBIOTIC AGENT; PR 39; PROPHENIN 1; PROPHENIN 2; PROTEGRIN; RL 37; SMAP 29; SMAP 34; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BIOSYNTHESIS; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; DRUG MECHANISM; DRUG RESEARCH; DRUG STRUCTURE; EPITHELIUM; GENE SEQUENCE; GENE TRANSFER; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; MOUTH INFECTION; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN LOCALIZATION; REVIEW; SEQUENCE ANALYSIS; SPECIES DISTRIBUTION; STRUCTURE ANALYSIS; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; MAMMALS;

MAMMALIA;

EID: 22944458199     PISSN: 14673037     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (158)

1. Agerberth, B., Lee, J.Y., Bergman, T., Carlquist, M., Boman, H.G., Mutt, V., and Jornvall, H. (1991). Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. J. Biochem. 202, 849-854.
2. Agerberth, B., Gunne, H., Oderberg, J., Kogner, P., Boman, H.G., and Gudmundsson, G.H. (1995). FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA. 92, 195-199.
3. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H., and Gudmundsson, G.H. (2000). The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
4. Andersson, E., Sorensen, O. E., Frohm, B., Borregaard, N., Egesten, A., and Malm, J. (2002). Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum. Reprod. 17, 2529-2534.
5. Bagella, L., Scocchi, M., and Zanetti, M. (1995). cDNA sequences of three sheep myeloid cathelicidins. FEBS Lett. 376, 225-228.
6. Bals, R., Wang, X., Zasloff, M., and Wilson, J.M. (1998). The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc. Natl. Acad. Sci. USA. 95, 9541-9546.
7. Bals, R., Weiner, D.J., Meegalla, R.L., and Wilson, J.M. (1999a). Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J. Clin. Invest. 103, 1113-1117.
8. Bals, R., Weiner, D.J., Moscioni, A.D., Meegalla, R.L., and Wilson, J.M. (1999b). Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect. Immun. 67, 6084-6089.
9. Bals, R., Lang, C., Weiner, D.J., Vogelmeier, C., Welsch, U., and Wilson, J.M. (2001). Rhesus monkey (Macaca mulatta) mucosal antimicrobial peptides are close homologues of human molecules. Clin. Diagn. Lab. Immunol. 8, 370-375.
10. Basanez, G., Shinnar, A.E., and Zimmerberg, J. (2002). Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes. FEBS Lett. 532, 115-120.
11. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L., and Lose, E.J. (1992). Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu. Rev. Cell Biol. 8, 365-393.
12. Blankenvoorde, M.F., van't Hof, W., Walgreen-Weterings, E., van Steenbergen, T.J., Brand, H.S., Veerman, E.C., and Nieuw Amerongen, A.V. (1998). Cystatin and cystatin-derived peptides have antibacterial activity against the pathogen Porphyromonas gingivalis. Biol. Chem. 379, 1371-1375.
13. Boman, H.G., Agerberth, B., and Boman, A. (1993). Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect. Immun. 61, 2978-2984.
14. Brogden, K.A., Kalfa, V.C., Ackermann, M.R., Palmquist, D.E., McCray, P.B. Jr, and Tack, B.F. The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob. Agents Chemother. 45, 331-334.
15. Castiglioni, B., Scocchi, M., Zanetti, M., and Ferretti, L. (1996). Six antimicrobial peptide genes of the cathelicidin family map to bovine chromosome 22q24 by fluorescence in situ hybridization. Cytogen. Cell. Genet. 75, 240-242.
16. Ceccarelli, A.V., Cole,A.M., Park, A.K., Tahk, S., Yoshioka, D., and Ganz, T. (2001). Therapeutic effect of a pig-derived peptide antibiotic on porcine wound infections. Comp. Med. 51, 75-79.
17. Chan, Y.R., and Gallo, R.L. (1998). PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J. Biol. Chem. 213, 28978-28985.
18. Cole, A.M., Shi, J., Ceccarelli, A., Kim, Y.H., Park, A., and Ganz, T. (2001). Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97, 297-304.
19. Com, E., Bourgeon, F., Evrard, B., Ganz, T., Colleu, D., Jegou, B., and Pineau, C. (2003). Expression of antimicrobial defensins in the male reproductive tract of rats, mice, and humans. Biol. Reprod. 68, 95-104.
20. Conner, K., Nern, K., Rudisill, J., O'Grady, T., and Gallo, R.L. (2062). The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris. J. Am. Acad. Dermatol. 47, 347-350.
21. Cowland, J.B., Johnsen, A.H., and Borregaard, N. (1995). hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil specific granules. FEBS Lett. 368, 173-176.
22. Del Sal, G., Storici, P., Schneider, C., Romeo, D., and Zanetti, M. (1992). cDNA cloning of the neutrophil bactericidal peptide indolicidin. Biochem. Biophys. Res. Commun. 187, 467-472.
23. De Yang, Chen, Q., Schmidt, A.P., Anderson, G.M., Wang, J.M., Wooters, J., Oppenheim, J.J., and Chertov, O. (2000). LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074.
24. Di Nardo, A., Vitiello, A., and Gallo, R.L. (2003). Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J. Immunol. 170, 2274-2278.
25. Dorschner, R.A., Pestonjamasp, V.K., Tamakuwala, S., Ohtake, T., Rudisill, J., Nizet, V., Agerberth, B., Gudmundsson, G.H., and Gallo, R.L. (2001). Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J. Invest. Dermatol. 117, 91-97.
26. Dorschner, R.A., Lin, K.H., Murakami, M., and Gallo, R.L. (2003). Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatr. Res. 53, 566-572.
27. Frohm, M., Gunne, H., Bergman, A.C., Agerberth, B., Bergman, T., Boman, A., Liden, S., Jornvall, H., and Boman, H.G. (1996). Biochemical and antibacterial analysis of human wound and blister fluid. Eur. J. Biochem. 237, 86-92.
28. Frohm, M., Agerberth, B., Ahangari, G., Stahle-Backdahl, M., Liden, S., Wigzell, H., and Gudmundsson, G.H. (1997). The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 272, 15258-15263.
29. Frohm Nilsson, M., Sandstedt, B., Sorensen, O., Weber, G., Borregaard, N., and Stahle-Backdahl, M. (1999). The human cationic antimicrobial protein (hCAP-18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 67, 2561-2566.
30. Gallo, R.L., Ono, M., Povsic, T., Page, C., Eriksson, E., Klagsbrun, M., and Bernfield, M. (1994). Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. USA. 91, 11036-11039.
31. Gallo, R.L., Kim, K.J., Bernfield, M., Kozak, C.A., Zanetti, M., Merluzzi, L., and Gennaro, R. (1997). Identification of CRAMP, a cathelin related antimicrobial peptide expressed in the embryonic and adult mouse. J. Biol. Chem. 272, 13088-13093.
32. Gao, Y., Lecker, S., Post, M.J., Hietaranta, A.J., Li, J., Volk, R., Li, M., Sato, K., Saluja, A. K., Steer, M.L., Goldberg, A.L., and Simons, M. (2000). Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. J. Clin. Invest. 106, 439-448.
33. Gennaro R., Skerlavaj B., and Romeo D. (1989). Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun. 57, 3142-3146.
34. Gennaro, R., and Zanetti, M. (2000). Structural features and biological activities of the cathelicidin-derived antimicrobial peptides. Biopolymers 55, 31-49.
35. Gennaro, R., Zanetti, M., Benincasa, M., Podda, E., and Miani, M. (2002). Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8, 763-778.
36. Giacometti, A., Cirioni, O., Del Prete, M.S., Skerlavaj, B., Circo, R., Zanetti, M., and Scalise, G. (2003a). In vitro effect on Cryptosporidium parvum of short-term exposure to cathelicidin peptides. J. Antimicrob. Chemother. 51, 843-847.
37. Giacometti, A., Cirioni, O., Ghiselli, R., Mocchegiani, F., D'Amato, G., Circo, R., Orlando, F., Skerlavaj, B., Silvestri, C., Saba, V., Zanetti, M., and Scalise, G. (2003b). Cathelicidin peptide SMAP-29 Prevents Endotoxin-Induced Mortality in Rat Models of Septic Shock. Am. J. Respir. Crit. Care. Med. (Epub ahead of print).
38. Gudmundsson, G.H., Magnusson, K.P., Chowdhary, B.P., Johansson, M., Andersson, L., and Boman, H.G. (1995). Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39. Proc. Natl. Acad. Sci. USA. 92, 7085-7089.
39. Gudmundsson, G.H.,Agerberth, B., Odeberg,J., Bergman, T., Olsson, B., and Salcedo, R. (1996). The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238, 325-332.
40. Hamill, K.G., Liu, Q., Sivashanmugam, P., Yenugu, S., Soundararajan, R., Grossman, G., Richardson, R.T., Zhang, Y.L., O'Rand, M.G., Petrusz, P., French, F.S., and Hall, S.H. (2002). Cystatin 11: a new member of the cystatin type 2 family. Endocrinology 143, 2787-2796.
41. Hammami-Hamza, S., Doussau, M., Bernard, J., Rogier, E., Duquenne, C., Richard, Y., Lefevre, A., and Finaz, C. (2001). Cloning and sequencing of SOB3, a human gene coding for a sperm protein homologous to an antimicrobial protein and potentially involved in zona pellucida binding. Mol. Hum. Reprod. 7, 625-632.
42. Hase, K., Eckmann, L., Leopard, J.D., Varki, N., and Kagnoff, M.F. (2002). Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect. Immun. 70, 953-963.
43. Heilborn, J.D., Nilsson, M.F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., and Stahle-Backdahl, M. (2003). The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
44. Henzler Wildman, K.A., Lee, D.K., and Ramamoorthy, A. (2003). Mechanism of lipid bilayer disruption by the human antimicrobial peptide, LL-37. Biochemistry 42, 6545-6558.
45. Hirata, M., Shimomura, Y., Yoshida, M., Morgan, J.G., Palings, I., Wilson, D., Yen, M.H., Wright, S.C., and Larrick, J.W. (1994). Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity. Infect. Immun. 62, 1421-1426.
46. Huang, H.J., Ross, C.R., and Blecha, F. (1997). Chemoattractant properties of PR-39, a neutrophil antibacterial peptide. J. Leukoc. Biol. 61, 624-629.
47. Huttner, K.M., Lambeth, M.R., Burkin, H.R., Burkin, D.J., and Broad, T.E. (1998). Localization and genomic organization of sheep antimicrobial peptide genes. Gene 206, 85-91.
48. Islam, D., Bandholtz, L., Nilsson, J., Wigzell, H., Christensson, B., Agerberth, B., and Gudmundsson, G. (2001). Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 7, 180-185.
49. Isogai, E., Isogai, H., Matuo, K., Hirose, K., Kowashi, Y., Okumuara, K., and Hirata, M. (2003) Sensitivity of genera Porphyromonas and Prevotella to the bactericidal action of C-terminal domain of human CAP18 and its analogues. Oral Microbiol. Immunol. 18, 329-332.
50. Johansson, J., Gudmundsson, G.H., Rottenberg, M.E., Berndt, K.D., and Agerberth, B. (1998). Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 273, 3718-3724.
51. Jung, H.H., Chae, S.W., Jung, S.K., Kim, S.T., Lee, H.M. and Hwang, S.J. (2003). Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma. Laryngoscope 113, 432-435.
52. Kim, S.T., Cha, H.E., Kim, D.Y., Han, G.C., Chung, Y.S., Lee, Y.J., Hwang, Y.J., and Lee, H.M. (2003). Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol. 23, 81-85.
53. Kirikae, T., Hirata, M., Yamasu, H., Kirikae, F., Tamura, H., Kayama, F., Nakatsuka, K., Yokochi, T., and Nakano, M. (1998). Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect. Immun. 66, 1861-1868.
54. Koczulla, R., Von Degenfeld, G., Kupatt, C., Krotz, F., Zahler, S., Gloe, T., Issbrucker, K., Unterberger, P., Zaiou, M., Lebherz, C., Karl, A., Raake, P., Pfosser, A., Boekstegers, P., Welsch, U., Hiemstra, P.S., Vogelmeier, C., Gallo, R.L., Clauss, M., and Bals, R. (2003). An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 111, 1665-1672.
55. Kokryakov, V.N., Harwig, S.S.L., Panyutich, E.A., Shevchenko, A.A., Aleshina, G.M., Shamova, O.V., Korneva, H.A., and Lehrer, R.I. (1993). Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett. 327, 231-236.
56. Kopitar, M., Ritonja, A., Popovic, T., Gabrijelcic, D., Krizaj, I., and Turk, V. (1989). A new type of low-molecular mass cysteine proteinase inhibitor from pig leukocytes. Biol. Chem. Hoppe. Seyler. 370, 1145-1151.
57. Korthuis, R.J., Gute, D.C., Blecha, F., and Ross, C.R. (2000). PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am. J. Physiol. Heart Circ. Physiol. 277, H1007-H1013.
58. Larrick, J.W., Morgan, J.G., Palings, I., Hirata, M., and Yen, M.H. (1991). Complementary DNA sequence of rabbit CAP18a unique lipopolysaccharide binding protein. Biochem. Biophys. Res. Commun. 179, 170-175.
59. Larrick, J.W., Hirata, M., Zheng, H., Zhong, J., Bolin, D., Cavaillon, J.M., Warren, H.S., and Wright, S.C. (1994). A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J. Immunol. 152, 231-240.
60. Larrick, J.W., Hirata, M., Balint, R.F., Lee, J., Zhong, J., and Wright, S.C. (1995). Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein. Infect. Immun. 63, 1291-1297.
61. Larrick, J.W., Lee, J., Ma, S., Li, X., Francke, U., Wright, S.C., and Balint, R.F. (1996). Structural, functional analysis and localization of the human CAP18 gene. FEBS Lett. 398, 74-80.
62. Levy, O., Weiss, J., Zarember, K., Ooi, C.E., and Elsbach, P. (1993). Antibacterial 15-kDa protein isoforms (p15s) are members of a novel family of leukocyte proteins. J. Biol. Chem. 268, 6058-60.
63. Li, J., Post, M., Volk, R., Gao, Y., Li, M., Metais, C., Sato, K., Tsai, J., Aird, W., Rosenberg, R., Hampton, T.G., Li, J., Sellke, F., Carmeliet, P., and Simons, M. (2000). PR-39, a peptide regulator of angiogenesis. Nat. Med. 6, 49-55.
64. Lynn, D.J., Higgs, R., Gaines, S., Tierney, J., James, T., Lloyd, A.T., Fares, M.A., Mulcahy, G. and O'Farrelly, C. (2004). Bioinformatic discovery and initial characterisation of nine novel antimicrobial peptide genes in the chicken. Immunogenetics 56, 170-177.
65. Lysenko, E.S., Gould, J., Bals, R., Wilson, J.M., and Weiser, J.N. (2000). Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. Infect. Immun. 68, 1664-1671.
66. Liu, A.Y., Destoumieux, D., Wong, A.V., Park, C.H., Valore, E.V., Liu, L., and Ganz, T. (2002). Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol. 118, 275-281.
67. Liu, L., Roberts, A.A., and Ganz, T. (2003). By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J. Immunol. 170, 575-580.
68. Mahoney, M.M., Lee, A.Y., Brezinski-Caliguri, D.J., and Huttner, K.M. (1995). Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide. FEBS Lett. 377, 519-522.
69. Malm, J., Sorensen, O., Persson, T., Frohm-Nilsson, M., Johansson, B., Bjartell, A., Lilja, H., Stahle-Backdahl, M., Borregaard, N., and Egesten, A. (2000). The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa. Infect. Immun. 68, 4297-4302.
70. Marchini, G., Lindow, S., Brismar, H., Stabi, B., Berggren, V., Ulfgren, A.K., Lonne-Rahm, S., Agerberth, B., and Gudmundsson, G.H. (2002). The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa. Br. J. Dermatol. 147, 1127-1134.
71. McGwire, B.S., Olson, C.L., Tack, B.F., and Engman, D.M. (2003). Killing of African trypanosomes by antimicrobial peptides. J. Infect. Dis. 188, 146-152.
72. Midorikawa, K., Ouhara, K., Komatsuzawa, H., Kawai, T., Yamada, S., Fujiwara, T., Yamazaki, K., Sayama, K., Taubman, M.A., Kurihara, H., Hashimoto, K., and Sugai, M. (2003). Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71, 3730-3739.
73. Moscinski, L.C., and Hill, B. (1995). Molecular cloning of a novel myeloid granule protein. J. Cell Blochem. 59, 431-442.
74. Murakami, M., Ohtake, T., Dorschner, R.A., Schittek, B., Garbe, C., and Gallo, R.L. (2002a). Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J. Invest. Dermatol. 119, 1090-1095.
75. Murakami, M., Ohtake, T., Dorschner, R.A., and Gallo, R.L. (2002b). Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J. Dent. Res. 81, 845-850.
76. Nagaoka, I., Tsutsumi-Ishii, Y., Yomogida, S., and Yamashita, T.J. (1997). Isolation of cDNA encoding guinea pig neutrophil cationic antibacterial polypeptide of 11 kDa (CAP11) and evaluation of CAP11 mRNA expression during neutrophil maturation. Biol. Chem. 272, 22742-22750.
77. Nagaoka, I., Hirota, S., Yomogida, S., Ohwada, A., and Hirata, M. (2000). Synergistic actions of antibacterial neutrophil defensins and cathelicidins. Inflamm. Res. 49, 73-79.
78. Niyonsaba, F., Hirata, M., Ogawa, H., and Nagaoka, I. (2003). Epithelial cell-derived antibacterial peptides human beta-defensins and cathelicidin: multifunctional activities on mast cells. Curr. Drug Targets Inflamm. Allergy 2, 224-231.
79. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., Pestonjamasp, V., Piraino, J., Huttner, K., and Gallo, R.L. (2001). Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414, 454-457.
80. Nizet, V., and Gallo, R.L. (2003). Cathelicidins and innate defense against invasive bacterial infection. Scand. J. Infect. Dis. 35, 670-676.
81. Nomura, I, Goleva, E., Howell, M.D., Hamid, Q.A., Ong, P.Y., Hall, C.F., Darst, M.A., Gao, B., Boguniewicz, M., Travers, J.B., and Leung, D.Y. (2003). Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171, 3262-3269.
82. Ohgami, K., Ilieva, I.B., Shiratori, K., Isogai; E., Yoshida, K., Kotake, S., Nishida, T., Mizuki, N., and Ohno, S. (2003). Effect of human cationic antimicrobial protein 18 Peptide on endotoxin-induced uveitis in rats. Invest. Ophthalmol. Vis. Sci. 44, 4412-4418.
83. Ong, P.Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R.L., and Leung, D.Y. (2002). Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160.
84. Oren, Z., Lerman, J.C., Gudmundsson, G.H., Agerberth, B., and Shai, Y. (1999). Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem. J. 341, 501-513.
85. Panyutich, A., Shi, J., Boutz, P.L., Zhao, C., and Ganz, T. (1997). Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins. Infect. Immun. 65, 978-985.
86. Paulsen, F., Pufe, T., Conradi, L., Varoga, D., Tsokos, M., Papendieck, J., and Petersen, W. (2003). Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J. Pathol. 198, 369-377.
87. Popsueva, A.E., Zinovjeva, M.V., Visser, J.W.M., Zijlmans, J.M., Fibbe, W.E., and Belyavsky, A.V. (1996). A novel murine cathelin-like protein expressed in bone marrow. FEBS Lett. 391, 5-8.
88. Putsep, K., Carlsson, G., Boman, H. G., and Andersson, M. (2002). Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149.
89. Ramanathan, B., Wu, H., Ross, C.R., and Blecha, F. (2003). PR-39, a porcine antimicrobial peptide, inhibits apoptosis: involvement of caspase-3. Dev. Comp. Immunol. 28, 163-169.
90. Risso, A., Zanetti, M., and Gennaro, R. (1998). Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell. Immunol. 189, 107-115.
91. Risso, A., Braidot, E., Sordano, M.C., Vinello, A., Macrì, F., Skerlavaj, B., Zanetti, M., Gennaro, R., and Bernardi, P. (2002). BMAP-28, an antibiotic peptide of innate immunity, induces cell death through opening of the mitochondrial permeability transition pore. Mol. Cell. Biol. 22, 1926-1935.
92. Ritonja, A., Kopitar, M., Jerala, R., and Turk, V. (1989). Primary structure of a new cysteine proteinase inhibitor from pig leucocytes. FEBS Lett. 255, 211-214.
93. Romeo, D., Skerlavaj, B., Bolognesi, M., and Gennaro, R. (11988). Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils. J. Biol. Chem. 263, 9573-9575.
94. Saiman, L., Tabibi, S., Starner, T.D., San Gabriel, P., Winokur, P.L., Jia, H.P., McCray, P.B. Jr, and Tack, B.F. (2001). Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob. Agents Chemother. 45, 2838-2844.
95. Sanchez, J.F., Hoh, F., Strub, M.P., Aumelas, A., and Dumas, C. (2002). Structure of the cathelicidin motif of protegrin-3 precursor: structural insights into the activation mechanism of an antimicrobial protein. Structure (Camb) 10, 1363-1370.
96. Schaller-Bals, S., Schulze, A., and Bals, R. (2002). Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection. Am. J. Respir. Crit. Care Med. 165, 992-995.
97. Schauber, J., Svanholm, C., Termen, S., Iffland, K., Menzel, T., Scheppach, W., Melcher, R., Agerberth, B., Luhrs, H., and Gudmundsson, G.H. (2003). Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 52, 735-741.
98. Scheetz, T., Bartlett, J.A., Walters, J.D., Schutte, B.C., Casavant, T.L., and McCray, P.B. Jr. (2002). Genomics-based approaches to gene discovery in innate immunity. Immunol. Rev. 190, 137-145.
99. Schmidtchen, A., Frick, I.M., Andersson, E., Tapper, H., and Bjorck, L. (2002). Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol. Microbiol. 46, 157-168.
100. Scocchi, M., Skerlavaj, B., Romeo, D., and Gennaro, R. (1992). Proteolytic cleavage by neutrophil elastase converts inactive storage proforms to antibacterial bactenecins. Eur. J. Biochem. 209, 589-595.
101. Scocchi, M., Romeo, D., and Zanetti, M. (1994). Molecular cloning of Bac7, a proline- and arginine- rich antimicrobial peptide from bovine neutrophils. FEBS Lett. 352, 197-200.
102. Scocchi, M., Wang, S., and Zanetti, M. (1997). Structural organization of the bovine cathelicidin gene family and identification of a novel member. FEBS Lett. 417, 311-315.
103. Scocchi, M., Bontempo, D., Boscolo, S., Tomasinsig, L., Giulotto, E., and Zanetti, M. (1999). Novel cathelicidins in horse leukocytes. FEBS Lett. 57, 459-464.
104. Scott, M.G., Davidson, D.J., Gold, M.R., Bowdish, D., and Hancock, R.E. (2002). The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
105. Selsted, M.E., Novotny, M.J., Morris, W.L., Tang, Y.-Q., Smith, W., and Cullor, J.S. (1992). Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 267, 4292-4295.
106. Shamova, O., Brogden, K.A., Zhao, C., Nguyen, T., Kokryakov, V.N., and Lehrer, R.I. (1999). Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect. Immun. 67, 4106-4111.
107. Shi, J., Ross, C.R., Chengappa, M.M., Sylte, M.J., McVey, D.S., and Blecha, F. (1996a). Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a proline-arginine-rich neutrophil antimicrobial peptide. Antimicrob. Agents Chemother. 40, 115-121.
108. Shi, J., Ross, C.R., Leto, T.L., and Blecha, F. (1996b). PR-39, a proline-rich antibacterial peptide that inhibits phagocyte NADPH oxidase activity by binding to Src homology 3 domains of p47 phox. Proc. Natl. Acad. Sci. USA. 93, 6014-6018.
109. Shoemaker, K., Holloway, J.L., Whitmore, T.E., Maurer, M., and Feldhaus, A.L. (2000). Molecular cloning, chromosome mapping and characterization of a testis-specific cystatin-like cDNA, cystatin T. Gene. 245, 103-108.
110. Skerlavaj, B., Gennaro, R., Bagella, L., Merluzzi, L., Risso, A., and Zanetti, M. (1996). Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities. J. Biol. Chem. 271, 28375-28381.
111. Smeianov, V., Scott, K., and Reid, G. (2000). Activity of cecropin P1 and FA-LL-37 against urogenital microflora. Microbes Infect. 2, 773-777.
112. Sorensen, O., Cowland, J.B., Askaa, J., and Borregaard, N. (1997a). An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J. Immunol. Methods. 206, 53-59.
113. Sorensen, O., Arnljots, K., Cowland, J.B., Bainton, D.F., and Borregaard, N. (1997b). The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803.
114. Sorensen, O., Bratt, T., Johnsen, A.H., Madsen, M.T., and Borregaard, N. (1999). The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma. J. Biol. Chem. 274, 22445-22451.
115. Sorensen, O.E., Follin, P., Johnsen, A.H., Calafat, J., Tjabringa, G.S., Hiemstra, P.S., and Borregaard, N. (2001). Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97, 3951-3959.
116. Sorensen, O.E., Cowland, J.B., Theilgaard-Monch, K., Liu, L., Ganz, T., and Borregaard, N. (2003a). Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J. Immunol. 170, 5583-5589.
117. Sorensen, O.E., Gram, L., Johnsen, A.H., Andersson, E., Bangsboll, S., Tjabringa, G.S., Hiemstra, P.S., Malm, J., Egesten, A., and Borregaard, N. (2003b). Processing of seminal plasma hCAP-18 to ALL-38 by gastricsin: a novel mechanism of generating antimicrobial peptides in vagina. J. Biol. Chem. 278, 28540-28546.
118. Storici, P., Del Sal, G., Schneider, C., and Zanetti, M. (1992). cDNA sequence analysis of an antibiotic dodecapeptide from neutrophils. FEBS Lett. 314, 187-190.
119. Storici, P., and Zanetti, M. (1993a). A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39. Biochem. Biophys. Res. Commun. 196, 1058-1065.
120. Storici, P., and Zanetti, M. (1993b). Anovel cDNAsequence encoding a pig leukocyte antimicrobial peptide with a cathelin-like pro-sequence. Biochem. Biophys. Res. Commun. 196, 1363-1368.
121. Storici, P., Scocchi, M., Tossi, A., Gennaro, R., and Zanetti, M. (1994). Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA. FEBS Lett. 337, 303-307.
122. Storici, P., Tossi, A., Lenarcic, B., and Romeo, D. (1996). Purification and structural characterization of bovine cathelicidins, precursors of antimicrobial peptides. Eur. J. Biochem. 238, 769-776.
123. Strukelj, B., Pungercar, J., Kopitar, G., Renko, M., Lenarcic, B., Berbic, S., and Turk, V. (1995). Molecular cloning and identification of a novel porcine cathelin-like antibacterial peptide precursor. Biol. Chem. Hoppe Seyler 376, 507-510.
124. Taggart, C.C., Greene, C.M., Smith, S.G., Levine, R.L., McCray, P.B. Jr, O'Neill, S., and McElvaney, N.G. (2003). Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins. J. Immunol. 171, 931-937.
125. Tanaka, D., Miyasaki, K.T., and Lehrer, R.I. (2000). Sensitivity of Actinobacillus actinomycetemcomitans and Capnocytophaga spp. to the bactericidal action of LL-37: a cathelicidin found in human leukocytes and epithelium. Oral Microbiol. Immunol. 15, 226-231.
126. Termen, S., Tollin, M., Olsson, B., Svenberg, T., Agerberth, B., and Gudmundsson, G. H. (2003). Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell. Mol. Life 60, 536-549.
127. Tjabringa, G.S., Aarbiou, J., Ninaber, D.K., Driffhout, J.W., Sorensen, O.E., Borregaard, N., Rabe, K.F., and Hiemstra, RS. (2003). The Antimicrobial Peptide LL-37 Activates Innate Immunity at the Airway Epithelial Surface by Transactivation of the Epidermal Growth Factor Receptor. J. Immunol. 171, 6690-6666.
128. Tomasinsig, L., Scocchi, M., Di Loreto, C., Artico, D., and Zanetti, M. (2002). Inducible expression of an antimicrobial peptide of the innate immunity in polymorphonuclear leukocytes. J. Leukoc. Biol. 72, 1003-1010.
129. Tossi, A., Scocchi, M., Zanetti, M., Storici, P., and Gennaro, R. (1995). PMAP-37, a novel pig myeloid antibacterial peptide. Eur. J. Biochem. 228, 941-946.
130. Tossi, A., Sandri, L., and Giangaspero, A. (2000). Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55, 4-30.
131. Tsutsumi-Ishii, Y., and Nagaoka I. (2003). Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production. J. Immunol. 170, 4226-4236.
132. Turner, J., Cho, Y., Dinh, N.N., Waring, A.J., and Lehrer, R.I. (1998). Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 42, 2206-2214.
133. Uzzell, T., Stolzenberg, E.D., Shinnar, A.E., and Zasloff, M. (2003). Hagfish intestinal antimicrobial peptides are ancient cathelicidins. Peptides 24, 1655-1667.
134. Verbanac, D., Zanetti, M., and Romeo, D. (1993). Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett. 317, 255-258.
135. Wang, Y., Agerberth, B., Lothgren, A., Almstedt, A., and Johansson, J. (1998). Apolipoprotein A-I binds and inhibits the human antibacterial/cytotoxic peptide LL-37. J. Biol. Chem. 273, 33115-33118.
136. Warren, H.S., Matyal, R., Allaire, J.E., Yarmush, D., Loiselle, P., Hellman, J., Paton, B.G., and Fink, M.P. (2003). Protective efficacy of CAP18106-138-immunoglobulin G in sepsis. J. Infect. Dis. 188, 1382-1393.
137. Wiese, A., Gutsmann, T., and Seydel, U. (2003). Towards antibacterial strategies: studies on the mechanisms of interaction between antibacterial peptides and model membranes. J. Endotoxin Res. 9, 67-84.
138. Wright, W.W., Smith, L., Kerr, C., and Charron, M. (2003). Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis. Biol. Reprod. 68, 380-687.
139. Wu, H., Zhang, G., Ross, C.R., and Blecha, F. (1999). Cathelicidin gene expression in porcine tissues: roles in ontogeny and tissue specificity. Infect. Immun. 67, 439-442.
140. Wu, H., Zhang, G., Minton, J.E., Ross, C.R., and Blecha, F. (2000). Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection. Infect. Immun. 68, 5552-5568.
141. Yan, H., and Hancock, R.E. (2001). Synergistic interactions between mammalian antimicrobal peotides. Antimicrob. Agents Chemother. 45, 1558-1560.
142. Yang, Y., Sanchez, J.F., Strub, M.P., Brutscher, B., and Aumelas, A. (2003). NMR structure of the cathelin-like domain of the protegrin-3 precursor. Biochemistry 42, 4669-80.
143. Yang, Y.H., Zheng, G.G., Li, G., Zhang, B., Song, Y.H., and Wu, K.F. (2003). Expression of LL-37/hCAP-18 gene in human leukemia cells. Leuk. Res. 27, 947-950.
144. Yenugu, S., Hamil, K.G., Birse, C.E., Ruben, S.M., French, F.S., and Hall, S.H. (2003). Antibacterial properties of the sperm-binding proteins and peptides of human epididymis 2 (HE2) family; salt sensitivity, structural dependence and their interaction with outer and cytoplasmic membranes of Escherichia coli. Biochem. J. 372, 473-483.
145. Yount, N.Y., Yuan, J., Tarver, A., Castro, T., Diamond, G., Tran, P.A., Levy, J.N., McCullough, C., Cullor, J.S., Bevins, C.L., and Selsted, M.E. (1999). Cloning and expression of bovine neutrophil beta-defensins. Biosynthetic profile during neutrophilic maturation and localization of mature peptide to novel cytoplasmic dense granules. J. Biol. Chem. 274, 26249-26258.
146. Zaiou, M., Nizet, V., and Gallo, R.L. (2003). Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J. Invest. Dermatol. 120, 810-816.
147. Zanetti, M., Litteri, L., Gennaro, R., Horstmann, H., and Romeo, D. (1990). Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large
148. Zanetti, M., Litteri, L., Griffiths, G., Gennaro, R., and Romeo, D. (1991). Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. J. Immunol. 146, 4295-4300.
149. Zanetti, M., Del Sal, G., Storici, P., Schneider, C., and Romeo, D. (1993). The cDNA sequence of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor, that is common to other neutrophil antibiotics. J. Biol. Chem. 268, 522-526.
150. Zanetti, M., Storici, P., Tossi, A., Scocchi, M., and Gennaro, R. (1994). Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells. J. Biol. Chem. 269, 7855-7858.
151. Zanetti, M., Gennaro, R., and Romeo, D. (1995). Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett. 374, 1-5.
152. Zanetti, M., Gennaro, R., Scocchi, M., and Skerlavaj B. (2000). Structure and biology of cathelicidins. Adv. Exp. Med. Biol. 479, 203-218.
153. Zanetti, M., Gennaro, R., Skerlavaj, B., Tomasinsig, L., and Circo, R. (2002). Cathelicidin peptides as candidates for a novel class of antimicrobials. Curr. Pharm. Des. 8, 779-793.
154. Zarember, K.A., Katz, S.S., Tack, B.F., Doukhan, L., Weiss, J., and Elsbach, P. (2002). Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes. Infect. Immun. 70, 569-576.
155. Zhao, C., Liu, L., and Lehrer, R.I. (1994). Identification of a new member of the protegrin family by cDNA cloning. FEBS Lett. 346, 285-288.
156. Zhao, C., Ganz, T., and Lehrer, R.I. (1995a). The structure of porcine protegrin genes. FEBS Lett. 368, 197-202.
157. Zhao, C., Ganz, T., and Lehrer, R.I. (1995b). Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. FEBS Lett. 376, 130-134.
158. Zhao, C., Nguyen, T., Boo, L.M., Hong, T., Espiritu, C., Orlov, D., Wang, W., Waring, A., and Lehrer, R.I. (2001). RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey. Antimicrob. Agents Chemother. 45, 2695-2702.